• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性局灶节段性肾小球硬化症患者血浆增加人足细胞脂滴形成和脂滴包被蛋白 2 的表达。

Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes.

机构信息

Department of Nephrology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, 6525 GA Nijmegen, The Netherlands.

出版信息

Int J Mol Sci. 2022 Dec 22;24(1):194. doi: 10.3390/ijms24010194.

DOI:10.3390/ijms24010194
PMID:36613637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9820489/
Abstract

Many patients with primary focal segmental glomerulosclerosis (FSGS) develop recurrence of proteinuria after kidney transplantation. Several circulating permeability factors (CPFs) responsible for recurrence have been suggested, but were never validated. We aimed to find proteins involved in the mechanism of action of CPF(s) and/or potential biomarkers for the presence of CPF(s). Cultured human podocytes were exposed to plasma from patients with FSGS with presumed CPF(s) or healthy and disease controls. Podocyte proteomes were analyzed by LC-MS. Results were validated using flow cytometry, RT-PCR, and immunofluorescence. Podocyte granularity was examined using flow cytometry, electron microscopy imaging, and BODIPY staining. Perilipin-2 protein expression was increased in podocytes exposed to presumed CPF-containing plasmas, and correlated with the capacity of plasma to induce podocyte granularity, identified as lipid droplet accumulation. Elevated podocyte perilipin-2 was confirmed at protein and mRNA level and was also detected in glomeruli of FSGS patients whose active disease plasmas induced podocyte perilipin-2 and lipid droplets. Our study demonstrates that presumably, CPF-containing plasmas from FSGS patients induce podocyte lipid droplet accumulation and perilipin-2 expression, identifying perilipin-2 as a potential biomarker. Future research should address the mechanism underlying CPF-induced alterations in podocyte lipid metabolism, which ultimately may result in novel leads for treatment.

摘要

许多原发性局灶节段性肾小球硬化症(FSGS)患者在肾移植后会出现蛋白尿复发。已经提出了几种负责复发的循环通透性因子(CPF),但从未得到验证。我们旨在寻找参与 CPF(s)作用机制的蛋白质和/或 CPF(s)存在的潜在生物标志物。将培养的人足细胞暴露于推测含有 CPF(s)的 FSGS 患者或健康和疾病对照的血浆中。通过 LC-MS 分析足细胞蛋白质组。使用流式细胞术、RT-PCR 和免疫荧光法验证结果。使用流式细胞术、电子显微镜成像和 BODIPY 染色检查足细胞的颗粒度。暴露于推测含有 CPF 的血浆中的足细胞中 perilipin-2 蛋白表达增加,并且与血浆诱导足细胞颗粒度的能力相关,这被鉴定为脂滴积累。升高的足细胞 perilipin-2 在蛋白质和 mRNA 水平上得到证实,并在其活动期血浆诱导足细胞 perilipin-2 和脂滴的 FSGS 患者的肾小球中也检测到。我们的研究表明,来自 FSGS 患者的含有 CPF 的血浆可能会诱导足细胞脂滴积累和 perilipin-2 表达,从而将 perilipin-2 鉴定为潜在的生物标志物。未来的研究应该解决 CPF 诱导的足细胞脂质代谢改变的机制,这最终可能为治疗提供新的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/0d8f0c62b8e9/ijms-24-00194-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/5eaf6188cd4f/ijms-24-00194-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/9902cac3d42c/ijms-24-00194-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/bd650bac4ca6/ijms-24-00194-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/e08b4e8db14c/ijms-24-00194-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/6c1ae3c0d4ee/ijms-24-00194-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/1986003de2d5/ijms-24-00194-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/a8fbc5992c8d/ijms-24-00194-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/0d8f0c62b8e9/ijms-24-00194-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/5eaf6188cd4f/ijms-24-00194-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/9902cac3d42c/ijms-24-00194-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/bd650bac4ca6/ijms-24-00194-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/e08b4e8db14c/ijms-24-00194-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/6c1ae3c0d4ee/ijms-24-00194-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/1986003de2d5/ijms-24-00194-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/a8fbc5992c8d/ijms-24-00194-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/967c/9820489/0d8f0c62b8e9/ijms-24-00194-g008.jpg

相似文献

1
Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes.原发性局灶节段性肾小球硬化症患者血浆增加人足细胞脂滴形成和脂滴包被蛋白 2 的表达。
Int J Mol Sci. 2022 Dec 22;24(1):194. doi: 10.3390/ijms24010194.
2
Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis.新型体外检测方法用于检测特发性局灶节段性肾小球硬化症中的循环通透性因子。
Nephrol Dial Transplant. 2021 Jan 25;36(2):247-256. doi: 10.1093/ndt/gfaa211.
3
Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.足细胞中非肌肉肌球蛋白重链-IIA 的表达在特发性肾病综合征中减少,尤其是在局灶节段性肾小球硬化中。
Nephrol Dial Transplant. 2013 Dec;28(12):2993-3003. doi: 10.1093/ndt/gft350. Epub 2013 Sep 15.
4
Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.鉴定局灶节段性肾小球硬化症患者血清中激活的肾小球和足细胞特异性基因和途径。
PLoS One. 2019 Oct 3;14(10):e0222948. doi: 10.1371/journal.pone.0222948. eCollection 2019.
5
Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.小鼠模型中的局灶节段性肾小球硬化:肾小球CD44和WT1表达的免疫组化相关性的组织学和超微结构特征
Ultrastruct Pathol. 2018 Sep-Oct;42(5):430-439. doi: 10.1080/01913123.2018.1501125. Epub 2018 Oct 4.
6
Permeability factors in focal and segmental glomerulosclerosis.局灶节段性肾小球硬化症中的通透性因素
Adv Chronic Kidney Dis. 2014 Sep;21(5):417-21. doi: 10.1053/j.ackd.2014.05.010.
7
Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.原发性局灶节段性肾小球硬化症患者及慢性PAN处理大鼠中α3β1整合素的足细胞表达降低和足细胞耗竭
J Lab Clin Med. 2006 Feb;147(2):74-82. doi: 10.1016/j.lab.2005.08.011.
8
New Mutation of Coenzyme Q Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient.辅酶 Q 单加氧酶 6 新突变导致局灶节段性肾小球硬化患者的足细胞损伤。
Chin Med J (Engl). 2018 Nov 20;131(22):2666-2675. doi: 10.4103/0366-6999.245158.
9
Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.用于检测与复发性局灶节段性肾小球硬化相关的循环足细胞毒性因子的新型无偏倚检测方法。
Am J Physiol Renal Physiol. 2016 May 15;310(10):F1148-56. doi: 10.1152/ajprenal.00349.2015. Epub 2015 Dec 30.
10
Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.黄芩苷通过抑制 Notch1-Snail 轴介导的足细胞 EMT 减轻阿霉素诱导的局灶节段性肾小球硬化和蛋白尿。
Life Sci. 2020 Sep 15;257:118010. doi: 10.1016/j.lfs.2020.118010. Epub 2020 Jun 26.

引用本文的文献

1
Inflammation in glomerular diseases.肾小球疾病中的炎症
Front Immunol. 2025 Mar 4;16:1526285. doi: 10.3389/fimmu.2025.1526285. eCollection 2025.
2
Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases.靶向脂滴和脂滴相关蛋白:天然化合物对抗代谢性疾病的新视角。
Chin Med. 2024 Sep 4;19(1):120. doi: 10.1186/s13020-024-00988-w.
3
Potential biomarkers of recurrent FSGS: a review.复发性局灶节段性肾小球硬化症的潜在生物标志物:综述。

本文引用的文献

1
Therapeutic trials in adult FSGS: lessons learned and the road forward.成人 FSGS 的治疗试验:经验教训与前进道路。
Nat Rev Nephrol. 2021 Sep;17(9):619-630. doi: 10.1038/s41581-021-00427-1. Epub 2021 May 20.
2
Circulating perilipin 2 levels are associated with fat mass, inflammatory and metabolic markers and are higher in women than men.循环 perilipin 2 水平与脂肪量、炎症和代谢标志物相关,且女性高于男性。
Aging (Albany NY). 2021 Mar 17;13(6):7931-7942. doi: 10.18632/aging.202840.
3
Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
BMC Nephrol. 2024 Aug 12;25(1):258. doi: 10.1186/s12882-024-03695-8.
4
Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.血浆及经血浆处理的足细胞的蛋白质组学:在局灶节段性肾小球硬化中的应用
Int J Mol Sci. 2023 Jul 28;24(15):12124. doi: 10.3390/ijms241512124.
新型诊断和治疗技术揭示了复发性局灶节段性肾小球硬化症中代谢谱的变化。
Sci Rep. 2021 Feb 25;11(1):4577. doi: 10.1038/s41598-021-83883-w.
4
PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API.PANTHER 版本 16:修订后的家族分类、基于树的分类工具、增强子区域和广泛的 API。
Nucleic Acids Res. 2021 Jan 8;49(D1):D394-D403. doi: 10.1093/nar/gkaa1106.
5
Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.肾移植中复发性局灶节段性肾小球硬化的研究进展。
Nephron. 2020;144 Suppl 1:65-70. doi: 10.1159/000510748. Epub 2020 Dec 1.
6
Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis.新型体外检测方法用于检测特发性局灶节段性肾小球硬化症中的循环通透性因子。
Nephrol Dial Transplant. 2021 Jan 25;36(2):247-256. doi: 10.1093/ndt/gfaa211.
7
Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS.鞘脂信号在肾小球疾病中的作用:聚焦于糖尿病肾病和局灶节段性肾小球硬化症
J Cell Signal. 2020 Sep;1(3):56-69. doi: 10.33696/Signaling.1.013.
8
Perilipin2 inhibits diabetic nephropathy-induced podocyte apoptosis by activating the PPARγ signaling pathway. perilipin2 通过激活 PPARγ 信号通路抑制糖尿病肾病诱导的足细胞凋亡。
Mol Cell Probes. 2020 Oct;53:101584. doi: 10.1016/j.mcp.2020.101584. Epub 2020 May 5.
9
Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.足细胞特异性敲除 Asah1 基因的小鼠足细胞病和肾病综合征:肾小球中神经酰胺积累的作用。
Am J Pathol. 2020 Jun;190(6):1211-1223. doi: 10.1016/j.ajpath.2020.02.008. Epub 2020 Mar 16.
10
Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle.特发性肾病综合征与血清通透因子:分子之谜。
Cell Tissue Res. 2020 Feb;379(2):231-243. doi: 10.1007/s00441-019-03147-y. Epub 2019 Dec 17.